Versatile deployment options – including on-premises and Virtual Private Cloud (VPC) configurations – ensure enterprise-grade security and HIPAA compliance, which is crucial for meeting UK data protection regulations.

“Speech-to-text for enterprise use cases is not trivial, and there is a fundamental difference between voice AI platforms designed for enterprise use cases vs entertainment use cases,” said Kevin Fredrick, Managing Partner at OneReach.ai. “Deepgram’s Nova-3 model and Nova-3-Medical model, are leading voice AI offerings, including TTS, in terms of the accuracy, latency, efficiency, and scalability required for enterprise use cases.”

Benchmarking Nova-3 Medical: Accuracy, speed, and efficiency

Deepgram has conducted benchmarking to demonstrate the performance of Nova-3 Medical. The model claims to deliver industry-leading transcription accuracy, optimising both overall word recognition and critical medical term accuracy.

  • Word Error Rate (WER): With a median WER of 3.45%, Nova-3 Medical outperforms competitors, achieving a 63.6% reduction in errors compared to the next best competitor. This enhanced precision minimises manual corrections and streamlines workflows.
  • Keyword Error Rate (KER): Crucially, Nova-3 Medical achieves a KER of 6.79%, marking a 40.35% reduction in errors compared to the next best competitor. This ensures that critical medical terms – such as drug names and conditions – are accurately transcribed, reducing the risk of miscommunication and patient safety issues.

In addition to accuracy, Nova-3 Medical excels in real-time applications. The model transcribes speech 5-40x faster than many alternative speech recognition vendors, making it ideal for telemedicine and digital health platforms. Its scalable architecture ensures high performance even as transcription volumes increase.

Furthermore, Nova-3 Medical is designed to be cost-effective. Starting at $0.0077 per minute of streaming audio – which Deepgram claims is more than twice as affordable as leading cloud providers – it allows healthcare tech companies to reinvest in innovation and accelerate product development.

Deepgram’s Nova-3 Medical aims to empower developers to build transformative medical transcription applications, driving exceptional outcomes across healthcare.

(Photo by Alexander Sinn)

See also: Autoscience Carl: The first AI scientist writing peer-reviewed papers

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is co-located with other leading events including Intelligent Automation Conference, BlockX, Digital Transformation Week, and Cyber Security & Cloud Expo.

Explore other upcoming enterprise technology events and webinars powered by TechForge here.